Amgen, Microsoft, and Mondelez International have all been generously raising their payouts in recent years. These are growing businesses that generate strong profits, which enable them to boost their
Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.

2 Cheap High-Yield Dividend Stocks to Buy Now

11:15am, Tuesday, 25'th Jul 2023
Many high-yielding stocks are either too risky or too expensive. Amgen and Bristol Myers Squibb offer above-average dividend yields, attractive valuations, and a reasonable margin of safety.
Amgen is now down nearly 20% since last November as money continues to rotate from defensive sectors into tech. The biopharma company should benefit from the rapid emergence of biosimilars thanks to i
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Pharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to cyclical sectors, drug price negotiations and upcoming patent cliffs have muddied the outlook.

3 Biotech Stocks for Getting Rich in 2023

06:22am, Tuesday, 18'th Jul 2023
The biotech industry is constantly evolving due to being on the cutting edge of the healthcare industry's research and development. Large biotech companies such as Johnson and Johnson (NYSE: JNJ ), Me
Primarily on the strength of UnitedHealth Group's earnings, the Dow Jones gained 125 points, finishing higher every day this week

2 Best Biotech Stocks to Buy Right Now

08:50am, Friday, 14'th Jul 2023
Amgen and Pfizer each possess admirable product portfolios and pipelines. Both companies sport dividend yields approaching 4% to nearly 5%.

Is Amgen's Dividend Safe?

02:10pm, Thursday, 13'th Jul 2023
Since instituting a dividend program in 2011, Amgen stock has become a top passive income vehicle. Although the biotech is entering a period of slower growth, its dividend appears to be safe.
The brisk pace of biopharmaceutical deal making seen in the first half of this year may only accelerate in the months ahead, even as regulators take a hard look at some of the bigger deals, analysts s

Is Now the Right Time to Embrace Biotech ETFs?

12:34pm, Wednesday, 12'th Jul 2023
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Dow Jones Today: Index Jumps 300 Points

05:10pm, Tuesday, 11'th Jul 2023
The Dow Jones led all indexes by moving higher by nearly 1%, as investors anticipate tomorrow's key inflation data.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE